cancerbiology.dfci.harvard.edu
Cancer Biology Links
http://cancerbiology.dfci.harvard.edu/links.php
Department of Cancer Biology. Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities. Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research e...
i571.wikispaces.com
Introducing Cheminformatics: Navigating the world of chemical data - Introducing Cheminformatics
http://i571.wikispaces.com/Introducing+Cheminformatics
Skip to main content. Get your brand new Wikispaces Classroom now. And do "back to school" in style. Introducing Cheminformatics: Navigating the world of chemical data. Introducing Cheminformatics: Navigating the world of chemical data. The roots of what we now call cheminformatics began very early in the history of computing: 1950's for statistical models, 1960's for first computer representations. Communications of the ACM, Volume 55 Issue 11, November 2012, Pages 65-75. Chemoinformatics - an introduct...
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: April 2010
http://pharmarandd.blogspot.com/2010_04_01_archive.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Tuesday, April 13, 2010. Smarter products in the home: The future of wellness devices. To understand consumer experiences with and expectations around the “wellness devices,” IBM’s Institute for Business Value. The study is not published yet though. it will be launched at a webcast on April 21, 2010 9:00 am - 10:30 am EDT. You can register for this webcast through this link. The webcast will share:. IBM T...
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: Smarter products in the home: The future of wellness devices
http://pharmarandd.blogspot.com/2010/04/smarter-products-in-home-future-of.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Tuesday, April 13, 2010. Smarter products in the home: The future of wellness devices. To understand consumer experiences with and expectations around the “wellness devices,” IBM’s Institute for Business Value. The study is not published yet though. it will be launched at a webcast on April 21, 2010 9:00 am - 10:30 am EDT. You can register for this webcast through this link. The webcast will share:. IBM A...
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: Diabetes Epidemic in Emerging Markets
http://pharmarandd.blogspot.com/2010/03/diabetes-pandemic-in-emerging-markets.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Thursday, March 25, 2010. Diabetes Epidemic in Emerging Markets. The strategies of the largest biopharma companies have been adding focus to emerging markets for some time now. The NEJM published a paper today showing exactly why the focus is critical to the health of the population in those markets. You can read the paper here. The following graphic is sourced from bbc.co.uk. August 24, 2013 at 2:48 AM.
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: December 2009
http://pharmarandd.blogspot.com/2009_12_01_archive.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Thursday, December 10, 2009. Cloudy" Forecast for Clinical Cloud. Despite the odd title, the future of IBM's clinical cloud is clear blue! Link to the full article here. Subscribe to: Posts (Atom). Subscribe in a reader. NEW* Lee Taurman's - Pharma's New Commercial Reality Blog. There was an error in this gadget. IBM A marriage of minds: Making biopharmaceutical collaborations work.
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: July 2010
http://pharmarandd.blogspot.com/2010_07_01_archive.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Thursday, July 1, 2010. Roche and IBM Research target whole genome sequencing for $100 to $1000. The IBM Global Business Services Life Sciences Practice runs a biopartnering study every two years. Roche is consistently in the top 5 of that study and based on the announcement today one can see why. Quick and reliable DNA sequencing could help Roche find patients that react best to specific drugs, helping r...
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: May 2010
http://pharmarandd.blogspot.com/2010_05_01_archive.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Friday, May 21, 2010. The 2010 CEO Study - Life Sciences Edition. This study is the fourth edition of IBM's biennial Global CEO Study series. It includes a specific analysis of the Life Sciences industry. Link to the study. These conversations offer valuable insight into the agendas and actions of global leaders. So, what are these "Standouts" doing to thrive? Embody creative leadership,. The study is wel...
pharmarandd.blogspot.com
Pharmaceutical R&D Blog: Collaborative Innovation in Biomedicine Conference
http://pharmarandd.blogspot.com/2011/04/collaborative-innovation-in-biomedicine.html
Stuart Henderson, Partner at IBM Global Business Services - Consulting to Life Sciences R&D Clients. Friday, April 8, 2011. Collaborative Innovation in Biomedicine Conference. I had the opportunity to present this week at a conference on Collaborative Innovation. The conference delegates were very engaging and the presentations provoked a lot of dialog. Three of the key points I came away with were:. 1 Multiple Orchestrators in a Networked Model. 3 Small makes collaboration a necessity. IBM The eClinical...
SOCIAL ENGAGEMENT